Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vitor W Virginio"'
Autor:
Riobaldo M. R. Cintra, Alexandre A. S. Soares, Ikaro Breder, Daniel B. Munhoz, Joaquim Barreto, Sheila T. Kimura-Medorima, Pamela Cavalcante, Renata Zanchetta, Jessica Cunha Breder, Camila Moreira, Vitor W. Virginio, Isabella Bonilha, Jose Carlos Lima-Junior, Otavio R. Coelho-Filho, Vaneza L. W. Wolf, Gil Guerra-Junior, Daniela C. Oliveira, Rodrigo Haeitmann, Vicente H. R. Fernandes, Wilson Nadruz, Fernando R. P. Chaves, Carlos E. L. Arieta, Thiago Quinaglia, Andrei C. Sposito, ADDENDA-BHS2 trial investigators
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 11, Iss 1, Pp 1-12 (2019)
Abstract Background Endothelial dysfunction (ED) is a hallmark in type 2 diabetes mellitus (T2DM) that favor both atherogenesis and ischemia and reperfusion injury (IRI). Sodium-glucose-2 co-transporter inhibitors (SGLT2i) may hypothetically improve
Externí odkaz:
https://doaj.org/article/5e2356c782c640c6b2466becbf7dff18
Autor:
Julie Alejo, Camelia Iancu-Rubin, Stefania Pittaluga, Ian Mohr, Grace Smith, Judith S. Hochman, Hannah M. Burgess, Seda Bilaloglu, Mark S. Lifshitz, MacIntosh Cornwell, Tessa J. Barrett, Homam Ibrahim, Jun Wang, Vitor W Virginio, Yin Aphinyanaphongs, Eugene Yuriditsky, Jeffrey S. Berger, Feng Xia Liang, Kenneth A. Stapleford, Kelly V. Ruggles, Kamelia Drenkova, Amy Rapkiewicz
Publikováno v:
Journal of Thrombosis and Haemostasis
Objective Heightened inflammation, dysregulated immunity, and thrombotic events are characteristic of hospitalized COVID‐19 patients. Given that platelets are key regulators of thrombosis, inflammation, and immunity they represent prime candidates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f66f821fd318dac3ce8d5613b61ace7e
https://doi.org/10.1111/jth.15534
https://doi.org/10.1111/jth.15534